Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

fda_21_4_1_0

FDA approves first at-home coronavirus self-testing kit

November 18, 2020 Research and Development

The FDA has issued an Emergency Use Authorization for the first coronavirus self-testing kit for use at home that produces …
News
vaccination-1215279_960_720

Pfizer/BioNTech’s COVID-19 vaccine shows up to 95% efficacy in final analysis, including in over-65s

November 18, 2020 Research and Development BioNTech, COVID-19, Pfizer, Vaccine

Pfizer and BioNTech have backed up their promising interim Phase 3 data showing 90% efficacy for their COVID-19 vaccine candidate …
News
covid_cell_1

Pharmafile.com’s weekly COVID-19 news round-up

November 18, 2020 Research and Development

The coronavirus news this week focuses on the Pfizer-BioNTech vaccine, with clinical trial participants receiving the vaccine saying it created …
News
shutterstock_159488225

Renewed BARDA backing boosts J&J’s COVID-19 vaccine funding by $1bn

November 17, 2020 Manufacturing and Production, Research and Development BARDA, COVID-19, J&J, JJ, Janssen, Vaccine

Johnson & Johnson has said that it is injecting around $1 billion of funding into its research efforts to develop …
News
moderna_norwood_plant

UK secures 5m doses of Moderna’s vaccine after it shows 94.5% interim efficacy

November 17, 2020 Manufacturing and Production, Research and Development, Sales and Marketing COVID-19, Moderna, UK, Vaccine

US firm Moderna has swooped in with Phase 3 interim data for its own messenger RNA (mRNA) vaccine candidate, mRNA-1273, …
News
512px-ugur_sahin_01

BioNTech Chief says COVID-19 vaccine could mean “normal winter” next year

November 16, 2020 Research and Development, Sales and Marketing BioNTech, COVID-19, Pfizer, Vaccine

The advent of an effective vaccine could mean a return to normalcy by next winter, argues Professor Uğur Şahin, Professor …
News

J&J launches second global COVID-19 vaccine trial, evaluating two-dose regimen

November 16, 2020 Research and Development, Sales and Marketing COVID-19, J&J, JJ, Janssen, Vaccine

Johnson & Johnson has kicked off a second global Phase 3 trial to assess the safety and efficacy of its …
News
guido_rasi

Guido Rasi steps down as EMA’s Executive Director, Emer Cooke to become first female in the role

November 13, 2020 Medical Communications, Research and Development, Sales and Marketing COVID-19, EMA, EU, pharma

Professor Guido Rasi, Executive Director at the European Medicines Agency (EMA), serves his final day at the European regulator today, …
News
reuters_-_tatyana_makeyeva

First interim Phase 3 data shows promise for Russia’s Sputnik V COVID-19 vaccine

November 11, 2020 Research and Development COVID-19, Russia, Sputnik V, Vaccine

The first interim Phase 3 data for Russia’s Sputnik V COVID-19 vaccine have been released by the Gamaleya Research Center …
News
1200px-vaccine_image_1

Head of UK vaccine taskforce grilled over government investment into her private equity firm

November 11, 2020 Research and Development COVID, UK COVID, coronavirus

Kate Bingham, the Head of the British Government’s vaccine taskforce, is facing further questions over a conflict of interest as …
News
512px-curevac_in_tubingen_02

CureVac’s COVID-19 vaccine generates immune responses at Phase 1

November 11, 2020 Research and Development COVID-19, CureVac, pharma

German biopharma firm CureVac has unveiled interim analysis data from a Phase1 study of its messenger RNA (mRNA) COVID-19 vaccine, CVnCoV, …
News
gym_wiki

Hotels, gyms and restaurants carry highest COVID-19 spread risk, new study says

November 11, 2020 Research and Development COVID, coronavirus

Reopening hotels, gyms and restaurants carries the highest risk of spreading coronavirus, according to a new study. 
News
covid_cell_1

Pharmafile.com’s weekly COVID-19 news round-up

November 11, 2020 Research and Development

The COVID-19 news this week focuses on vaccines, with AstraZeneca committing to an agreement to deliver 22 million doses of …
News
vaccination-1215279_960_720

Pfizer and BioNTech’s COVID-19 vaccine shows 90% efficacy in interim analysis

November 10, 2020 Manufacturing and Production, Research and Development BioNTech, COVID-19, Pfizer, Vaccine

Pfizer and BioNTech have ignited a wave of hope with the announcement of positive Phase 3 data demonstrating that their …
News
shutter

AstraZeneca’s Brilinta combo reduces rate of disabling stroke or death in stroke patients, according to Phase 3 data

November 9, 2020 Research and Development, Sales and Marketing AstraZeneca, Brilinta, pharma

AstraZeneca has unveiled new Phase 3 data for Brilinta (ticagrelor) as a treatment for patients who have suffered an acute …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026